查看中文
In a consultation paper issued in June 2024, The Stock Exchange of Hong Kong Limited (HKEX) is proposing amendments to The Rules Governing the Listing of Securities on HKEX (the Listing Rules) to improve corporate...more
7/5/2024
/ Asia Pacific ,
Board of Directors ,
Capital Markets ,
Corporate Governance ,
Diversity ,
Environmental Social & Governance (ESG) ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Investment Management ,
Listing Rules ,
Proposed Amendments ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Risk Management ,
Shareholders
查看中文
This update provides an overview of key regulatory developments in the fourth quarter of 2023 relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their advisers....more
3/5/2024
/ Board of Directors ,
Capital Markets ,
Corporate Governance ,
Disclosure Requirements ,
Environmental Social & Governance (ESG) ,
Financial Regulatory Reform ,
Foreign Corporations ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Internal Controls ,
Listing Rules ,
Publicly-Traded Companies ,
Regulatory Agenda
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
7/14/2020
/ Acquisitions ,
Amended Rules ,
Biotechnology ,
Board of Directors ,
Censures ,
Corporate Executives ,
Enforcement Actions ,
False Statements ,
Hang Seng China Enterprises Index (HSCEI) ,
Hang Seng Index (HSI) ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Internal Controls ,
Listing Applications ,
Listing Rules ,
Medical Devices ,
Medical Research ,
Mergers ,
Misappropriation ,
Misleading Statements ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Sanctions ,
Secondary Listings ,
SFC ,
Shareholders ,
Takeovers ,
Weighted Voting Rights (WVR)
This update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
1/8/2020
/ Acquisitions ,
Annual Reports ,
Beneficial Owner ,
Board of Directors ,
Breach of Duty ,
Censures ,
Compensation ,
Complex Corporate Transactions ,
Conflicts of Interest ,
Controlling Person ,
Criminal Convictions ,
Cross-Border Transactions ,
Debt Securities ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Failure to Cooperate ,
Filing Deadlines ,
Foreign Acquisitions ,
Foreign Offerings ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Securities Clearing Company Limited (HKSCC) ,
Hong Kong Stock Exchange ,
Insider Trading ,
Investment Adviser ,
Listing Rules ,
Mandatory Disclosure Rules ,
Materiality ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Reporting Requirements ,
Secondary Listings ,
Shareholder Approval ,
Trial Court Orders
This edition provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In...more
7/5/2019
/ Accounting Standards ,
Acquisitions ,
Audit Policies ,
Board of Directors ,
CEOs ,
China ,
Conflicts of Interest ,
Controlling Stockholders ,
Criminal Prosecution ,
Disclosure Requirements ,
Disqualification ,
Due Diligence ,
Economic Sanctions ,
Enforcement Actions ,
Environmental Social & Governance (ESG) ,
Financial Reporting ,
Fines ,
Foreign Investment ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Insider Information ,
Listing Rules ,
Mergers ,
Non-GAAP Financial Measures ,
Office of Foreign Assets Control (OFAC) ,
Publicly-Traded Companies ,
Risk Assessment ,
The Market Misconduct Tribunal (MMT) ,
Trade Suspensions ,
Variable Interest Entities